Sai Life Sciences IPO GMP, Price, Allotment, Profit Estimate 2024

Sai Life Sciences IPO Description – Sai Life Sciences is the fastest-growing contract research, development, and manufacturing organization (CRDMO). It is also one of the few CRDMOs to have research laboratories for discovery and development located near overseas innovation hubs at Watertown (Greater Boston, MA), United States (US), and Manchester, United Kingdom (UK), complemented by large-scale research laboratories and manufacturing facilities in cost competitive locations in India.

The company has served more than 280 innovator pharmaceutical companies, including 18 of the top 25 pharmaceutical companies, across regulated markets, including the US, the UK, Europe, and Japan. It also provides CRO services to more than 60 customers on an ongoing basis, for their integrated drug discovery programs. As of 31 March 2024, its CDMO product portfolio included more than 150 innovative pharmaceutical products, including 38 products that were supplied for the manufacturing of 28 commercial drugs.

As of 31 March 2024, the company has 2,845 employees globally, including 2,125 scientific staff, with the majority of the scientific team holding advanced degrees, including 276 PhDs and 1,343 master’s degrees.

Promoters of Sai Life Sciences – Kanumuri Ranga Raju, Krishnam Raju Kanumuri, Kanumuri Mytreyi, Sai Quest Syn Private Limited, Marigold Partners, Sunflower Partners,Tulip Partners and Lily Partners

Sai Life Sciences IPO Details

Sai Life Sciences IPO Dates	11 – 13 December 2024
Sai Life Sciences Issue Price	INR 522 – 549 per share
Fresh issue	INR 950 crore
Offer For Sale	3,81,16,934 shares (INR 2,092.62 crore)
Total IPO size	INR 3,042.62 crore
Minimum bid (lot size)	27 shares (INR 14,823)
Face Value	INR 1 per share
Retail Allocation	35%
Listing On	NSE, BSE

Sai Life Sciences Financial Performance

	FY 2022	FY 2023	FY 2024
Revenue	869.59	1,217.13	1,465.17
Expenses	888.04	1,228.69	1385.03
Net income	6.22	9.98	82.80
Margin (%)	0.17	0.81	5.65

Figures in INR Crores unless specified otherwise

Sai Life Sciences Offer News

Sai Life Sciences Valuations & Margins

	FY 2022	FY 2023 (Pre Issue)	FY 2024 (Post-Issue)*
EPS	0.34	0.55	4.39
PE Ratio	–	–	–

* Calculated on the basis of annualized Profits After Tax for FY 2024

	FY 2022	FY 2023	FY 2024
RONW (%)	0.71	1.12	8.13
NAV	48.90	49.18	53.83
ROCE (%)	3.21	5.13	10.26
EBITDA (%)	15.07	14.97	20.48
Debt/Equity	0.84	0.80	0.75

*Compiled by IPO Central from Prospectus

Sai Life Sciences IPO GMP Today (Daily Trend)

Sai Life Sciences IPO Objectives

The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:

Repayment/ prepayment, in full or part, of all or certain outstanding borrowings availed by the Company – INR 600 crore
General corporate purposes

Sai Life Sciences IPO Subscription – Live Updates

Category	QIB	NII	Retail	Employee	Total
Shares Offered	–	–	–	–	–

Sai Life Sciences – Comparison With Listed Peers

Company	PE ratio	EPS	RONW (%)	NAV	Revenue (Cr.)
Sai Life Sciences	–	4.39	8.13	53.94	1,465.17
Divi’s Laboratories	79.51	60.27	11.79	511.21	7845
Suven Pharmaceuticals	78.36	11.80	14.64	94.04	1051.35
Syngene International	61.70	12.69	11.98	105.91	3488.6

Sai Life Sciences IPO Allotment Status

Sai Life Sciences IPO allotment status will be available on the KFin Tech website. Click on this link to get allotment status.

Sai Life SciencesIPO Dates & Listing Performance

IPO Opening Date	11 December 2024
IPO Closing Date	13 December 2024
Finalization of Basis of Allotment	16 December 2024
Initiation of refunds	17 December 2024
Transfer of shares to demat accounts	17 December 2024
Sai Life Sciences IPO Listing Date	18 December 2024
Opening Price on NSE	Coming soon
Closing Price on NSE	Coming soon

Angel One –
Anand Rathi –
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital –
Ashika Research –
BP Wealth –
Capital Market –
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Elara Capital –
Elite Wealth –
GCL Broking –
Geojit –
GEPL Capital –
Hem Securities –
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –
Jainam Broking –
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Mehta Equities –
Nirmal Bang –
Reliance Securities –
Sushil Finance –
Samco Securities –
SBI Securities –
SMC Global –
SMIFS –
Systematix Research –
Swastika Investmart –
Ventura Securities –

Sai Life Sciences Offer Lead Manager

IIFL SECURITIES LIMITED
24th Floor, One Lodha Place, Senapati Bapat Marg,
Lower Parel (West) Mumbai 400 013 Maharashtra
Phone: +91 22 4646 47283
Email: [email protected]
Website: www.axiscapital.co.in

Sai Life Sciences Offer Registrar

KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com

SAI LIFE SCIENCES LIMITED
L4- 01 & 02, SLN Terminus Survey, Survey no. 133, Gachibowli Miyapur Road,
Gachibowli, Hyderabad 500 032, Telangana, India
Phone: +91 40 6815 6000
Email: [email protected]
Website: www.sailife.com

Sai Life Sciences IPO FAQs

How many shares in Sai Life Sciences IPO are reserved for HNIs and retail investors?

The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.

How to apply for Sai Life Sciences Public Offer?

The best way to apply for Sai Life Sciences public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.